Skip to content
Fiscal Receipts

Chemical and Biological Weapons Elimination Technology Improvement

OSDRDT&EPartial Reconciliation0607162D8Z
What it is
Chemical and Biological Weapons Elimination Technology Improvement — a research & development program run by OSD.
What changed
-$9.39M FY25→26
Who gets it
No award linkage at high confidence.

Budget Figures

FY24 Actuals
FY25 Total
$11.8M
FY26 Request
$2.36M
FY25→26 Change
-$9.39M
Budget Trajectory
FY25: $11.8MFY26: $2.36MFY25FY26
FY25
$11.8M
FY26
$2.36M

FY2026 award data is a partial year — USASpending awards are reported on a rolling basis and the fiscal year does not close until September 30. why →

No research dossier for this program — dossiers cover 50 of 326 programs, ranked by FY2026 requested dollars. why →

Budget Line Items(workbook-cited)

Exhibit R-1

AccountOrgTypeAmount
Research, Development, Test and Evaluation, Defense-WideOSDFY25 Enacted$11.8M
Research, Development, Test and Evaluation, Defense-WideOSDFY25 Total$11.8M
Research, Development, Test and Evaluation, Defense-WideOSDFY26 Disc. Request$2.36M
Research, Development, Test and Evaluation, Defense-WideOSDFY26 Total$2.36M

Budget Details(R-2/P-40 facts)

ProjectAll Prior YearsFY25 TotalFY26 BaseFY26 Request
Program Element$0$11.8M$2.36M$2.36M
548: ChemBio Weapons Elim Tech Impr$0$11.8M$2.36M$2.36M

Program Narratives

MissionChemBio Weapons Elim Tech Impr

Chemical and biological weapons (CBW)-based threats continue to evolve in response to changing geopolitics and emerging technologies. Each of the nations that are deemed as threats to United States (U.S.) national security are believed to have and/or be developing chemical and/or biological weapons. The Department of Defense (DoD) must be prepared to eliminate these threats during and/or after the execution of a contingency operation or in support of a diplomatic breakthrough, enabling the U.S. to achieve peace through strength and strengthening deterrence. Chemical Weapons Convention (CWC) and Biological Weapons Convention (BWC) obligations and DoD strategic guidance demand the Department maintain a complete and enduring capability to assess and destroy CBW, regardless of location or environment. In accordance with the CWC and BWC, the U.S. must be prepared to “destroy [chemical/biological] weapons…in its possession or…under its jurisdiction or control.” It is critical for the DoD to possess the capabilities to directly disable or defeat WMD threats prior to use. This capability must provide operational flexibility that enables early action and expedient destruction, from small-scale disablement and defeat in a non-permissive or austere environment to large-scale destruction of a foreign CBW stockpile in a post-contingency or permissive environment. Our current capabilities are inadequate to support these requirements, and we are currently unable to invest in the development and/or improvement of capabilities to eliminate CBW on the scale required. The Department must be proactive in ensuring we are prepared to eliminate known and expected CBW threats before adversary use against U.S. military or civilian personnel at home or abroad or our allies. The Chemical and Biological Weapons Elimination (CBWE) Research and Development Activities (RDAs)support the Department’s initiatives to rebuild our military and reestablish deterrence by ensuring a complete and enduring capability to assess and destroy chemical and biological weapons (CBW), regardless of location or operational environment. This program addresses Joint Force priorities, tasks, and requirements. Fiscal Year (FY) 2026 funding is for the advanced development of chemical weapons destruction capabilities in support of Joint Warfighter and U.S. Recovered Chemical Warfare Material requirements. The CBWE portfolio provides material solutions that enable DoD to prevent adversary acquisition, transfer, deployment, and use of CBW as well as meet U.S. Chemical Warfare Convention (CWC) treaty obligations. The CBWE portfolio will execute along several Lines of Effort (LOEs) to help prepare the Joint Force for a future operating environment in which adversary possession of Weapons of Mass Destruction (WMDs) pose threats ranging from tactical to existential, and limit U.S. strategic choices. These LOEs will create options for assessment and destruction of recovered chemical warfare material within the U.S., as well as chemical and biological warfare material across the continuum of conflict, including materiel solutions for the destruction of small-scale and bulk CBW agents, and solutions for the elimination of nation state CBW programs and stockpiles. The Office of the Secretary of Defense uses the CBWE Portfolio to invest strategically in projects to fill validated requirements from the Services, Combatant Commands, combat support agencies, and defense agencies. Funding is prioritized for projects that close Joint Force and domestic assess, disable and/or destroy capability gaps. An annual investment strategy is used to prioritize and meet capability needs. The CBWE Technology Improvement program invests in upgrades and enhancements to fielded systems used to assess, disable, and/or destroy chemical and biological weapons and material – foreign and domestic. Funds are used for integration of operational prototypes into fielded systems, or other upgrades and enhancements, including any necessary test and evaluation. This program funds labor, materials, and travel requirements, performed by a government agency or by private individuals or organizations under a contract with the government, for activities and acquisitions including Research, Development, Test & Evaluation (RDT&E), assessments and analyses, and other activities related to capability development and fielding.

MissionChemBio Weapons Elimination Technology Improvement

Chemical and biological weapons (CBW)-based threats continue to evolve in response to changing geopolitics and emerging technologies. Each of the nations that are deemed as threats to United States (U.S.) national security are believed to have and/or be developing chemical and/or biological weapons. The Department of Defense (DoD) must be prepared to eliminate these threats during and/or after the execution of a contingency operation or in support of a diplomatic breakthrough, enabling the U.S. to achieve peace through strength and strengthening deterrence. Chemical Weapons Convention (CWC) and Biological Weapons Convention (BWC) obligations and DoD strategic guidance demand the Department maintain a complete and enduring capability to assess and destroy CBW, regardless of location or environment. In accordance with the CWC and BWC, the U.S. must be prepared to “destroy [chemical/biological] weapons…in its possession or…under its jurisdiction or control.” It is critical for the DoD to possess the capabilities to directly disable or defeat WMD threats prior to use. This capability must provide operational flexibility that enables early action and expedient destruction, from small-scale disablement and defeat in a non-permissive or austere environment to large-scale destruction of a foreign CBW stockpile in a post-contingency or permissive environment. Our current capabilities are inadequate to support these requirements, and we are currently unable to invest in the development and/or improvement of capabilities to eliminate CBW on the scale required. The Department must be proactive in ensuring we are prepared to eliminate known and expected CBW threats before adversary use against U.S. military or civilian personnel at home or abroad or our allies. The Chemical and Biological Weapons Elimination (CBWE) Research and Development Activities (RDAs)support the Department’s initiatives to rebuild our military and reestablish deterrence by ensuring a complete and enduring capability to assess and destroy chemical and biological weapons (CBW), regardless of location or operational environment. This program addresses Joint Force priorities, tasks, and requirements. Fiscal Year (FY) 2026 funding is for the advanced development of chemical weapons destruction capabilities in support of Joint Warfighter and U.S. Recovered Chemical Warfare Material requirements. The CBWE portfolio provides material solutions that enable DoD to prevent adversary acquisition, transfer, deployment, and use of CBW as well as meet U.S. Chemical Warfare Convention (CWC) treaty obligations. The CBWE portfolio will execute along several Lines of Effort (LOEs) to help prepare the Joint Force for a future operating environment in which adversary possession of Weapons of Mass Destruction (WMDs) pose threats ranging from tactical to existential, and limit U.S. strategic choices. These LOEs will create options for assessment and destruction of recovered chemical warfare material within the U.S., as well as chemical and biological warfare material across the continuum of conflict, including materiel solutions for the destruction of small-scale and bulk CBW agents, and solutions for the elimination of nation state CBW programs and stockpiles. The Office of the Secretary of Defense uses the CBWE Portfolio to invest strategically in projects to fill validated requirements from the Services, Combatant Commands, combat support agencies, and defense agencies. Funding is prioritized for projects that close Joint Force and domestic assess, disable and/or destroy capability gaps. An annual investment strategy is used to prioritize and meet capability needs. The CBWE Technology Improvement program invests in upgrades and enhancements to fielded systems used to assess, disable, and/or destroy chemical and biological weapons and material – foreign and domestic. Funds are used for integration of operational prototypes into fielded systems, or other upgrades and enhancements, including any necessary test and evaluation. This program funds labor, materials, and travel requirements, performed by a government agency or by private individuals or organizations under a contract with the government, for activities and acquisitions including Research, Development, Test & Evaluation (RDT&E), assessments and analyses, and other activities related to capability development and fielding.

Accomplishments & Planned Programs (1)

P*548 / ChemBio Weapons Elimination Technology Improvement

The CBWE program invests in materiel solutions through the improvement of technologies; developmental and operational test and evaluation; and transition to fielded capabilities that counter WMD proliferation. This program enables the transition of technologies to fielded capabilities by leveraging significant Science and Technology (S&T) investments made by the DoD, other Federal agencies, and industry.

No follow-the-dollar view — this program's awards haven't been crosswalked at high confidence (flows cover 17 of 326 programs). why →

Lobbying Mentions

Showing 25 of 223 from the Senate LDA disclosure database.

S 2226/HR 2670 - National Defense Authorization Act for Fiscal Year 2024 including issues related to aircraft, helicopte

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to making improvements to th

General issues related to defense spending, including for the F-35 program, in H.R. 8070, the Servicemember Quality of L

H.R. 8070- Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 H.R. 87

S 127/HR 3561 - Pharmacy Benefit Manager Transparency Act of 2023 including issues related Pharmacy Benefit Manager refo

General issues related to defense spending, including for the F-35 program, in H.R. 8070, the Servicemember Quality of L

H.R. 8070- Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 H.R. 87

S 4921/HR 8774 - Department of Defense Appropriations Act, 2025 including issues related to Air Force, Navy and Marine C

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives

General issues related to defense spending, including for the F-35 program, in H.R. 8070, the Servicemember Quality of L

H.R. 8070- Servicemember Quality of Life Improvement and National Defense Authorization Act for Fiscal Year 2025 H.R. 87

HR 7024 - Tax Relief for American Families and Workers Act of 2024 including issues related to providing tax incentives

S 2572/HR 4016 - Department of Defense Appropriations Act, 2026 including issues related to tactical aircraft, hypersoni

S 2572/HR 4016 - Department of Defense Appropriations Act, 2026 including issues related to tactical fixed wing aviation

S 2572/HR 4016 - Department of Defense Appropriations Act, 2026 including issues related to space, missile defense, clas

THE BOEING COMPANYImprovement2024

H.R. 3029, Primary Care Enhancement Act of 2023. Bipartisan HSA Improvement Act.

THE BOEING COMPANYImprovement2024

H.R. 3029, Primary Care Enhancement Act of 2023. Bipartisan HSA Improvement Act.

THE BOEING COMPANYImprovement2024

H.R. 3029, Primary Care Enhancement Act of 2023. Bipartisan HSA Improvement Act.

THE BOEING COMPANYChemical2026

Issues related to chemical usage.

BOEING COMPANYWeapons2024

FY24 Department of Defense Appropriations Act. FY24 Commerce, Justice, Science and Related Agencies Appropriations Act.

BOEING COMPANYImprovement2024

H.R. 824 - Telehealth Benefit Expansion for Workers Act of 2023. H.R. 1843 & S. 1001 - Telehealth Expansion Act of 2023.

BOEING COMPANYChemical2024

H.R. 3935, Securing Growth & Robust Leadership in American Aviation Act. S.1939, FAA Reauthorization Act of 2024. H.R. 6

BOEING COMPANYImprovement2024

H.R.824 - Telehealth Benefit Expansion for Workers Act of 2023. H.R.1843 & S.1001 - Telehealth Expansion Act of 2023. H.

BOEING COMPANYWeapons2024

FY24 Supplemental appropriations. FY25 Department of Defense Appropriations Act. FY25 State, Foreign Operations, and Rel

BOEING COMPANYChemical2024

FAA Reauthorization Act of 2024. H.R.6271 - Farm to Fly Act of 2023. FY25 Agriculture, Rural Development, Food and Drug

Primary Sources